Insider Transactions in Q4 2025 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2025
|
Leslie V Norwalk Director |
SELL
Open market or private sale
|
Direct |
1,190
-16.02%
|
$184,450
$155.09 P/Share
|
|
Dec 15
2025
|
Leslie V Norwalk Director |
SELL
Open market or private sale
|
Direct |
5,000
-40.23%
|
$760,000
$152.23 P/Share
|
|
Dec 15
2025
|
Leslie V Norwalk Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+27.89%
|
$880,000
$88.65 P/Share
|
|
Dec 08
2025
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,376
-9.16%
|
$695,784
$159.65 P/Share
|
|
Dec 08
2025
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,376
+8.39%
|
$188,168
$43.24 P/Share
|
|
Dec 03
2025
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
15,000
-11.07%
|
$2,280,000
$152.61 P/Share
|
|
Dec 03
2025
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+9.97%
|
$705,000
$47.89 P/Share
|
|
Nov 29
2025
|
Jude Onyia Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,248
-12.4%
|
$341,696
$152.16 P/Share
|
|
Nov 29
2025
|
Jude Onyia Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,426
+19.62%
|
-
|
|
Nov 28
2025
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,970
-11.74%
|
$901,470
$151.74 P/Share
|
|
Nov 28
2025
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,970
+10.5%
|
$208,950
$35.99 P/Share
|
|
Nov 25
2025
|
George J Morrow Director |
SELL
Open market or private sale
|
Direct |
15,000
-67.97%
|
$2,145,000
$143.37 P/Share
|
|
Nov 25
2025
|
George J Morrow Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+40.47%
|
$705,000
$47.89 P/Share
|
|
Nov 05
2025
|
William H Rastetter Director |
SELL
Open market or private sale
|
Direct |
18,000
-30.84%
|
$2,718,000
$151.82 P/Share
|
|
Nov 05
2025
|
William H Rastetter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+23.57%
|
$846,000
$47.89 P/Share
|
|
Nov 04
2025
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
300
-0.21%
|
$42,300
$141.97 P/Share
|
|
Nov 01
2025
|
Kyle Gano Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
613
+0.43%
|
-
|